Erenumab
Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine[1].
Product Specifications
CAS Number
1582205-90-0
Product Name Alternative
AMG-334
UNSPSC
12352203
Target
CGRP Receptor
Type
Inhibitory Antibodies
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/erenumab.html
Purity
98.88
Solubility
H2O
Smiles
[Erenumab]
Molecular Weight
(145.5 kDa)
References & Citations
[1]Goadsby PJ, Reuter U, Hallström Y, et al. A Controlled Trial of Erenumab for Episodic Migraine. N Engl J Med. 2017;377 (22) :2123-2132.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15352510 1 Vial
Lentiviral human CYP24A1 shRNA (UAS) - Lentiviral human CYP24A1 shRNA (UAS) plasmid
Sign In for Pricing
View Details 
NB110-67828C 0.1 mL
Mouse Monoclonal beta-Actin Antibody (AC-15) [DyLight 650]
Sign In for Pricing
View Details MBS1380878-01 0.02 mg (E-Coli)
Recombinant Mycobacterium bovis Protein grpE (grpE)
Sign In for Pricing
View Details MBS1380878-02 0.1 mg (E-Coli)
Recombinant Mycobacterium bovis Protein grpE (grpE)
Sign In for Pricing
View Details MBS1380878-03 0.02 mg (Yeast)
Recombinant Mycobacterium bovis Protein grpE (grpE)
Sign In for Pricing
View Details